cyclosporine and Human T-lymphotropic Virus 1 Infection

cyclosporine has been researched along with Human T-lymphotropic Virus 1 Infection in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haynes, RA; Lairmore, MD; Phipps, AJ; Premanandan, C; Ware, E; Yu, L; Zimmerman, B1
Blattner, W; Hamlin-Green, G; Mann, DL; Martin, P; Nalewaik, R1
Buckle, GJ; Hafler, DA; Höllsberg, P1
Andrada-Serpa, MJ; Araújo, AQ; Rumjanek, VM; Schor, D1
Ausubel, LJ; Bierer, BE; Calvo, V; Hafler, DA; Höllsberg, P; Wucherpfennig, KW1

Reviews

1 review(s) available for cyclosporine and Human T-lymphotropic Virus 1 Infection

ArticleYear
HTLV-I-induced T-cell activation.
    Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1996, Volume: 13 Suppl 1

    Topics: CD2 Antigens; CD28 Antigens; Cyclosporine; Cytokines; G1 Phase; Gene Products, tax; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Immunosuppressive Agents; Interleukin-2; Lymphocyte Activation; Polyenes; S Phase; Sirolimus; T-Lymphocytes; Tacrolimus

1996

Other Studies

4 other study(ies) available for cyclosporine and Human T-lymphotropic Virus 1 Infection

ArticleYear
Cyclosporine-induced immune suppression alters establishment of HTLV-1 infection in a rabbit model.
    Blood, 2010, Jan-28, Volume: 115, Issue:4

    Topics: Animals; CD4-CD8 Ratio; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Female; gag Gene Products, Human Immunodeficiency Virus; Gene Products, env; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Immunocompromised Host; Immunosuppressive Agents; Jurkat Cells; Lymphocytosis; Lymphoma, T-Cell; Rabbits; Retroviridae Proteins, Oncogenic; T-Lymphocytes, Helper-Inducer; Viral Load

2010
Virus production and spontaneous cell proliferation in HTLV-I-infected lymphocytes.
    Clinical immunology and immunopathology, 1994, Volume: 72, Issue:3

    Topics: Antibodies, Monoclonal; Antigens, Surface; Base Sequence; Cells, Cultured; Cyclosporine; DNA, Viral; HTLV-I Antigens; HTLV-I Infections; Human T-lymphotropic virus 1; Humans; Lymphocyte Activation; Molecular Sequence Data; Polymerase Chain Reaction; RNA, Viral; T-Lymphocyte Subsets; Virus Replication

1994
Immunological features of HTLV-I myelopathy in Rio de Janeiro, Brazil, and in vitro effects of cyclosporin A.
    Journal of the neurological sciences, 1996, Volume: 139, Issue:1

    Topics: Adolescent; Adult; Aged; Brazil; Cells, Cultured; Cyclosporine; Cytokines; Family; Female; HTLV-I Infections; Humans; Immunosuppressive Agents; Interleukin-2; Interleukin-6; Lymphocyte Activation; Male; Middle Aged; Paraparesis, Tropical Spastic; Reference Values; Tumor Necrosis Factor-alpha; Urban Population

1996
Characterization of HTLV-I in vivo infected T cell clones. IL-2-independent growth of nontransformed T cells.
    Journal of immunology (Baltimore, Md. : 1950), 1992, May-15, Volume: 148, Issue:10

    Topics: Antibodies, Monoclonal; Antigens, Differentiation, T-Lymphocyte; Base Sequence; CD3 Complex; Clone Cells; Cyclosporine; HTLV-I Infections; Humans; Interleukin-2; Lymphocyte Activation; Molecular Sequence Data; Polyenes; Receptors, Antigen, T-Cell; Receptors, Interleukin-2; RNA, Messenger; Sirolimus; T-Lymphocytes; Tacrolimus

1992